TET2 deletion + DNMT3A mutation
|
Melanoma
|
TET2 deletion + DNMT3A mutation
|
Melanoma
|
TdCyd Sensitive: D – Preclinical
|
TdCyd Sensitive: D – Preclinical
|
TET2 deletion + DNMT3A mutation
|
Kidney Cancer
|
TET2 deletion + DNMT3A mutation
|
Kidney Cancer
|
TdCyd Sensitive: D – Preclinical
|
TdCyd Sensitive: D – Preclinical
|
TET2 deletion + DNMT3A mutation
|
Lung Cancer
|
TET2 deletion + DNMT3A mutation
|
Lung Cancer
|
TdCyd Sensitive: D – Preclinical
|
TdCyd Sensitive: D – Preclinical
|
TET2 deletion + DNMT3A mutation
|
Breast Cancer
|
TET2 deletion + DNMT3A mutation
|
Breast Cancer
|
TdCyd Sensitive: D – Preclinical
|
TdCyd Sensitive: D – Preclinical
|